News
CBUS
17.11
+0.35%
0.06
Weekly Report: what happened at CBUS last week (0422-0426)?
Weekly Report · 3d ago
Weekly Report: what happened at CBUS last week (0415-0419)?
Weekly Report · 04/22 10:41
CIBUS INC <CBUS.O>: JEFFERIES RAISES TARGET PRICE TO $19 FROM $16
Reuters · 04/16 05:43
Weekly Report: what happened at CBUS last week (0408-0412)?
Weekly Report · 04/15 10:34
Weekly Report: what happened at CBUS last week (0401-0405)?
Weekly Report · 04/08 10:38
Weekly Report: what happened at CBUS last week (0325-0329)?
Weekly Report · 04/01 10:37
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised)
NASDAQ · 03/25 19:16
Weekly Report: what happened at CBUS last week (0318-0322)?
Weekly Report · 03/25 10:39
Market Fluctuations and Cibus Inc.: Navigating the Uncertain Terrain of Agricultural Commodity Prices
TipRanks · 03/23 06:01
Cibus Price Target Maintained With a $25.00/Share by HC Wainwright & Co.
Dow Jones · 03/22 15:02
Cibus Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 03/22 15:02
HC Wainwright & Co. Maintains Buy on Cibus, Maintains $25 Price Target
Benzinga · 03/22 14:52
Cibus’s Transition to Commercial Execution Prompts Buy Rating Amidst Strong Growth Prospects
TipRanks · 03/22 11:17
Cibus’s Market Potential and Advancements Justify Buy Rating
TipRanks · 03/22 10:16
CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023
Cibus just reported results for the fourth quarter of 2023. The company reported earnings per share of $1.87. This was above the analyst estimate for EPS of -$1.43. Cibus also reported revenue of 190.26% better than expected.
Investorplace · 03/22 00:52
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/21 22:50
*Cibus Expects Soybean Platform to Be Operational in 2024 >CBUS
Dow Jones · 03/21 20:11
*Cibus 4Q Rev $1.1M >CBUS
Dow Jones · 03/21 20:10
*Cibus 4Q Loss/Shr $12.59 >CBUS
Dow Jones · 03/21 20:09
Press Release: Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Cibus Reports Fourth Quarter Financial Results and Provides Business Update. Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits. Signed collaboration agreements for trait development with multiple major seed companies. Achieved world's first successful regeneration of Wheat plants from single cells.
Dow Jones · 03/21 20:05
More
Webull provides a variety of real-time CBUS stock news. You can receive the latest news about CIBUS INC through multiple platforms. This information may help you make smarter investment decisions.
About CBUS
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.